Caryn Lerman: Heinz Josef Lenz and his team identified novel predictive and prognostic biomarkers
Caryn Lerman, Director of USC Norris Comprehensive Cancer Center, shared on LinkedIn:
“Published in the Journal of Clinical Oncology, Dr. Heinz Josef Lenz, Deputy Director for Research Programs at USC Norris, and his team identified novel predictive and prognostic biomarkers to anti- vascular endothelial growth factor and anti- epidermal growth factor receptor antibodies, two key elements in the growth and dissemination of tumors, in a large cooperative clinical trial with a diverse patient population.
The findings have the potential to accelerate drug development strategies and lead to much needed improvement of outcome, particularly in African Americans patients. Read the full publication here.”
For the video attached in the post click here.
Source: Caryn Lerman/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023